Skip to content
Search

Latest Stories

PAIN MANAGEMENT: Managing pain in everyday practice

Drawing from her vast experience in pain management, pharmacist Bina Patel advises how empathy, talk therapy and psychological support can be useful in helping the patient…

The current pharmacy contract focuses on utilising pharmacists’ skills in the areas which can further support patient care closer to home and reduce the burden on secondary care and GP appointments. Pain management is one such area that I have found to be a step in the right direction.


Pain can be classified generally as acute or chronic and depending on the situation can be a complex mixture of syndromes. The patient suffering with pain may be struggling with many issues in their day-to-day life.

Many seek help to either support what is prescribed as it is not doing the trick and/or seek help to manage their condition as they have not wished to make ‘a big fuss’.

Managing pain conditions requires an exploration of an individual’s background issues along with the causes of the pain syndrome and the impact on the patient’s lifestyle.

Chronic pain is a complex syndrome to manage; ideally requiring a multi-disciplinary team input. Complexities can include psychological, physiological and financial issues.

Community pharmacists dispense medication to patients daily and are ideally placed to provide some input and support to improve both patient care and quality of life.

What skills do we possess?

A. Personal knowledge of the patient

B. Accessibility without appointments

C. Conducting confidential conversations in consultation rooms

D. Knowledge of the medication being prescribed, side effects etc.

E. Signposting awareness

F. Awareness of the risk of condition escalation and red flags for onward referral Patients are familiar with the pharmacy and are in regular contact with the pharmacist and their team.

In managing pain it is important to build a relationship with the patient and the pharmacist is ideally placed having an established rapport with the patient.

Talk therapy can be useful to understand and empathise with these patients and, may help offload some of their concerns particularly with social isolation caused by a number of factors.

Psychological support is key in supporting these patients as its impact is felt not only by the patient but also by the people they live or interact with. In my experience this relationship with the patients and their families has been an important factor in my role as a pharmacist.

Pharmacies are open for longer hours and can be accessed easily by patients. This is a key element in the current climate where GPs are struggling to give appointments or longer appointments which this kind of patient may need. Greater accessibility provides for a good

support network for patients within the community.

Consultations within the pharmacies can be conducted in private at any time of the working

day without appointment and has proven to be the main stay of many a pain patient in my practice.

This gives them the opportunity to offload some of their concerns or worries and personal issues that arise from the impact of the ‘syndrome’.

The pharmacist can also intervene by ensuring that the patient is aware of how to get the best out of their medication. This can be done by way of exploring the patient’s lifestyle and pain pattern. When do they experience most pain, what triggers off the pain and what are their main goals?

This background will help decide how the regimen can be altered to fit the lifestyle and pain cycle of the patient. Pain is an ‘algesic’ hence, looking at managing breakthrough pain will help improve a patient’s quality of life and build a rapport with them.

My experience has been in this area where talking to my patients exploring their pain causes, pain cycles, lifestyles and then trying to alter the regimen to suit their condition helps improve their quality of life.

Pharmacists can also help patients and support them through exploring side effects of the

analgesics, supporting patients when medication regimens are changed.

An explanation of how the medication works with the combination prescribed and how the drugs work hand in hand helps a patient understand why their medication is required to be

taken in the sequence or interval stipulated.

Several medications are used for their side effects and not their main licensed use which needs to be explained to patients. In my consultations this was identified as an issue that could be discussed at inception to avoid the subsequent concerns patients may raise.

Patients do not take the medication due to concerns and this delays improvement of pain management. Concordance is a key element of any regimen in managing any condition.

Pharmacists can emphasise this point as breakthrough pain and pain per se, need to be managed promptly by use of medication.

Explanation of a prescribed pain regimen will help the person control their pain cyclically through the course of the day.  Maintaining links with other professionals that could help in the patient’s care should be considered such as physiotherapists and counselling service professionals.

The patient has the choice, however signposting them to other sources where appropriate may help improve their quality of life. Complete management of pain is not always possible however a patient that is supported is likely to cope better. A pharmacist in the community is the face that is easily accessed and is ideally placed to provide this first step to patients once discharged into the community or patients simply trying to cope on a day-to-day

basis.

(Award-winning pharmacist Bina Patel runs Kalsons Chemist in Essex.)

More For You

Janet Morrison discusses pharmacy funding strategy at 2025 conference

Health Secretary Wes Streeting outlines government support for community pharmacy

CPE calls new funding deal a ‘reluctant yes’

Community Pharmacy England (CPE) was “reluctant” to accept the new pharmacy funding deal due to the significant funding gap, said the organisation’s chief executive Janet Morrison, while recognising the settlement as the first step towards stabilising the sector.

Addressing the 2025 Pharmacy Business Conference on Sunday at London Hilton Wembley, Janet shared insights into the behind-the-scenes work that led to the agreement.

Keep ReadingShow less
RPS transition to Royal College

RPS transition to Royal College: What it means for pharmacy

RPS transition to Royal College: What it means for pharmacy - Professor Claire Anderson explains

The Royal Pharmaceutical Society (RPS) is set to transition into a Royal College after securing majority support from its members in a recent ballot. However, concerns have been raised about the long-term implications of this shift.

With a voter turnout of 31.4%, 6,144 out of 19,594 eligible members participated in the vote on the Royal Charter changes. Of those, 71.1% supported the transition, well above the required two-thirds majority for a Special Resolution Vote.

Keep ReadingShow less
Pharmacies key to driving the shift from treatment to prevention

Bas Vorsteveld, Kenvue’s area managing director for Northern Europe.

Pharmacies can become frontline educators of self-care

Pharmacies have the potential to play a pivotal role in the government's transition from treatment-based healthcare to a more prevention-focused approach. However, for this shift to be successful, they require greater systemic support.

Bas Vorsteveld, Kenvue’s area managing director for Northern Europe, emphasises the importance of allowing pharmacists access to patient records to enable them to offer tailored advice and improve patient care.

Keep ReadingShow less
Community pharmacist consulting with a patient about independent prescribing.

Malcolm Harrison

Exclusive: National prescribing service 'critical' for community pharmacy, says Malcolm Harrison

A national prescribing service is “critical” for community pharmacy with all newly qualified pharmacists becoming independent prescribers from next year, according to Malcolm Harrison, chief executive of the Company Chemist Association (CCA).

“We are encouraging the NHS to work with community pharmacy to explore what that (prescribing service) could look like. There are pilots that are out there at the moment, and I know a number of pharmacies are engaged in those and exploring the different variations of what it could be,” Harrison told Pharmacy Business.

Keep ReadingShow less
Unlocking the potential of technology in pharmacy

Harry McQuillan, chairman, Numark

Technology in pharmacy goes beyond operational improvements

Community pharmacies are expected to take on greater responsibilities to ease pressure on other healthcare services and meet growing patient demands. However, despite their expanding role, they continue to lack adequate financial support.

“While funding negotiations continue, one thing remains clear, technology is key to ensuring pharmacy can thrive in a rapidly evolving healthcare landscape,” said Harry McQuillan, chairman of Numark.

Keep ReadingShow less